Show simple item record

dc.contributor.authorimray, chris
dc.date.accessioned2023-08-24T09:47:34Z
dc.date.available2023-08-24T09:47:34Z
dc.date.issued2012-10-31
dc.identifier.citationBMJ . 2012 Oct 31;345:e7077en_US
dc.identifier.eissn1756-1833
dc.identifier.doi10.1136/bmj.e7077
dc.identifier.pmid23114063
dc.identifier.urihttp://hdl.handle.net/20.500.14200/1921
dc.description.abstractNo abstract available. Comment on Identifying the lowest effective dose of acetazolamide for the prophylaxis of acute mountain sickness: systematic review and meta-analysis. Low EV, Avery AJ, Gupta V, Schedlbauer A, Grocott MP. BMJ. 2012 Oct 18;345:e6779. doi: 10.1136/bmj.e6779. PMID: 23081689en_US
dc.language.isoenen_US
dc.publisherBMJ Publishing Groupen_US
dc.subjectDiseases & disorders of systemic, metabolic or environmental originen_US
dc.titleAcetazolamide for the prophylaxis of acute mountain sickness.en_US
dc.typeArticle
dc.source.journaltitleBMJ
dc.source.volume345
dc.source.beginpagee7077
dc.source.endpage
dc.source.countryEngland
rioxxterms.versionNAen_US
dc.contributor.trustauthorimray, chris
dc.contributor.departmentSurgical Servicesen_US
dc.contributor.roleMedical and Dentalen_US
oa.grant.openaccessnaen_US


This item appears in the following Collection(s)

Show simple item record